NYSE American - Delayed Quote • USD
Palatin Technologies, Inc. (PTN)
At close: 4:00 PM EDT
After hours: 6:55 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.5 | -0.43 | -2.13 | -0.96 |
| Low Estimate | -0.66 | -0.67 | -3.06 | -1.26 |
| High Estimate | -0.35 | -0.27 | -1.65 | -0.66 |
| Year Ago EPS | -0.63 | -0.91 | -2.53 | -2.13 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | 80k | 90k | 4.29M | 7.48M |
| Low Estimate | -- | -- | 4.1M | 3M |
| High Estimate | 240k | 260k | 4.64M | 11.96M |
| Year Ago Sales | -- | 1.76M | 4.85M | 4.29M |
| Sales Growth (year/est) | -- | -94.90% | -11.60% | 74.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.56 | -0.41 | -0.2 |
| EPS Actual | -0.63 | -0.91 | -0.48 | -0.56 |
| Difference | -0.24 | -0.35 | -0.07 | -0.36 |
| Surprise % | -61.50% | -62.50% | -17.10% | -180.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.5 | -0.43 | -2.13 | -0.96 |
| 7 Days Ago | -0.5 | -0.43 | -2.13 | -0.96 |
| 30 Days Ago | -0.5 | -0.43 | -2.13 | -0.96 |
| 60 Days Ago | -0.5 | -0.43 | -2.13 | -0.96 |
| 90 Days Ago | -0.33 | -0.31 | -1.26 | -0.9 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PTN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 20.60% | -- | -- | 2.60% |
| Next Qtr. | 52.70% | -- | -- | 13.40% |
| Current Year | 15.80% | -- | -- | 5.20% |
| Next Year | 54.90% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/28/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/10/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/8/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/7/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/30/2023 |
Related Tickers
DOMH Dominari Holdings Inc.
2.7000
-3.23%
EYEN Eyenovia, Inc.
0.7113
+21.90%
BRTX BioRestorative Therapies, Inc.
1.2300
-3.15%
NRXP NRx Pharmaceuticals, Inc.
3.1400
+0.64%
BTAI BioXcel Therapeutics, Inc.
2.6100
-3.69%
MBIO Mustang Bio, Inc.
0.3504
+0.09%
VNDA Vanda Pharmaceuticals Inc.
4.4800
-1.75%
CDTX Cidara Therapeutics, Inc.
13.00
+5.78%
FBIO Fortress Biotech, Inc.
1.7200
-3.91%
BLRX BioLineRx Ltd.
0.5753
-6.15%